Due to the summer holidays, the VPH Conference 2018 Secretary will be
closed from July 27th until August 20th. Please, contact us before these weeks for any urgent matters.
VPHi MEET THE MENTOR LUNCHEON
For the second year at the VPH Conference, a group of experienced representatives of Industry and Academia from the VPH Community will gather with students to discuss and share advice on career projects and opportunities in the field. Join this event
All registered delegates for the VPH Conference can benefit of a 30% discount on the AVE High speed train to get to Zaragoza. We have sent personalized emails in order to provide your individual codes for this RENFE discount, if you have not received it, please contact organization of the congress at email@example.com. We recommend that you buy and print your AVE tickets in advance, if you are flying through Madrid or Barcelona. Purchase your ticket
INDUSTRY SESSION: In Silico clinical trials – a disruptive innovation for biomedical industry
One of the coming highlights of the VPH Conference 2018 will be the plenary
Industry Session on In Silico clinical trials as the next step for biomedical industry. This session aims to gather the main players of biomedical industries, key actors as Tina Morrison from the FDA and other platforms as Avicenna Alliance, Insigneo Institue CompBioMed. Looking forward to this exciting session!
CHANGE OF DATE: Assessing Credibility of Computational Modeling and Simulation pre-course
The ASME V&V40 Subcommittee Traning courses that was initially planned for Tuesday 4th at 16:00 will now take place on Friday 7th at 15:00, due to external commitments of the speakers. We apologize for any inconveniences this may cause, please contact us at firstname.lastname@example.org with any doubts.
VPH Insitute Networking session for European calls
A new special plenary session has been scheduled for VPH Conference 2018. Thanks to the VPH Institute is organizing a special networking event, on Wednesday 5th, right after the session “Insilico Medicine in FP9” with a NCP and EU representatives as speakers. It will be a great opportunity to find sinergies and new project partners. To attend the event, you must be a VPHi member and register
NEW PRE-COURSE: Assessing Credibility of Computational Modeling and Simulation
ASME V&V40 Subcommittee is organizing a new one pre-course for the VPH Conference 2018. Developed through close collaboration between device developers, regulatory agencies, and other device industry stakeholders, the V&V 40 standard provides modelers in the medical device industry with a framework for establishing model credibility requirements. This course will provide an overview of the standard and highlight the key tenants through a few medical device examples. Potential speakers are: Tina Morrison from US FDA and Marc Horner from ANSYS. More details to be confirmed.
Thanks to MEDTRONIC, exclusive industry sponsor of VPH 2018, students that submit their contribution to the conference can obtain a full registration grant. The 5 best contributions will be granted their registration. If you would like your work to be considered please email us at email@example.com referencing your work and your student certification before May 23rd.
CALL FOR ABSTRACTS SUBMISSION EXTENDED
The call for contributions for the VPH Conference 2018 has been extended until March 15th. See all the information to submit your Abstract to the conference
NEW SESSION: INSILICO MEDICINE IN FP9
A new special plenary session has been scheduled for VPH Conference 2018. Thanks to the VPH Institute, this session will be programmed on Wednesday 5th at 16:30 including an overview of the coming FP9 of In-Silico Medicine, info of coming H2020 funding calls and a networking session.
TINA MORRISON FROM THE FDA IS JOINING VPH 2018
We are pleased to announce the presence of FDA for the coming VPH Conference.
Tina Morrison, Deputy Director of Division of Applied Mechanics at U.S. Food and Drugs Administration will join the conference as a keynote speaker for one of the plenary sessions at the event. More details of this session will be shared soon.